Generation of fiber-modified adenovirus vectors containing heterologous peptides in both the HI loop and C terminus of the fiber knob

Journal of Gene Medicine

Volumn 5, Issue 4, 2003, Pages 267-276

  Koizumi, Naoya ^a,b   Mizuguchi, Hiroyuki ^a   Utoguchi, Naoki ^b,c   Watanabe, Yoshiteru ^b   Hayakawa, Takao ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^c School of Science   (Japan)

Author keywords

Adenovirus vector; Fiber; Gene therapy; Retargeting

Indexed keywords

ADENOVIRUS VECTOR; ARGINYLGLYCYLASPARTIC ACID; LYSINE; ARGINYL-GLYCYL-ASPARTIC ACID; CAPSID PROTEIN; HEPARIN LYASE; HEXON CAPSID PROTEIN, ADENOVIRUS; OLIGOPEPTIDE; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; EXPERIMENTAL DESIGN; GENE CONSTRUCT; GENE EXPRESSION; GENE FUNCTION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAMMAL CELL; METHODOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR CELL; VIRAL GENE DELIVERY SYSTEM; VIRUS FIBER; ADENOVIRUS; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN ENGINEERING; PROTEIN TERTIARY STRUCTURE;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CAPSID PROTEINS; CELLS, CULTURED; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEPARIN LYASE; HUMANS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY; RATS; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

EID: 0344661722     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.348     Document Type: Article

References (36)

1. Kovesdi I, Brough D, Bruder J, Wickham T. Adenoviral vectors for gene transfer. Curr Opin Biotechnol 1997; 8: 583-589.
2. Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999; 10: 440-447.
3. Bergelson JM, Cunningham JA, Droguett G, et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
4. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 1997; 94: 3352-3356.
5. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.
6. Wickham TJ, Filardo EJ, Cheresh DA, Nemerow GR. Integrin αvβ5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol 1994; 127: 257-264.
7. Wickham TJ. Targeting adenovirus. Gene Ther 2000; 7 110-114.
8. Wickham TJ, Tzeng E, Shears LL, et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol 1997; 71: 8221-8229.
9. Dmitriev I, Krasnykh V, Miller CR, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus. J Virol 1998; 72: 9706-9713.
10. Krasnykh V, Dmitriev I, Mikheeva G, Miller CR, Belousova N, Curiel DT. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol 1998; 72: 1844-1852.
11. Yoshida Y, Sadata A, Zhang W, Saito K, Shinoura N, Hamada H. Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma. Hum Gene Ther 1998; 9: 2503-2515.
12. Bouri K, Feero WG, Myerburg MM, et al. Poly-lysine modification of adenoviral fiber protein enhances muscle cell transduction. Hum Gene Ther 1999; 10: 1633-1640.
13. Koizumi N, Mizuguchi H, Hosono T, et al. Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide. Biochem Biophys Acta 2001; 1568: 13-20.
14. Mizuguchi H, Koizumi N, Hosono T, et al. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther 2001; 8: 730-735.
15. Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J Virol 1996; 70: 2116-2123.
16. Stevenson SC, Rollence M, Marshall-Neff J, McClelland A. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J Virol 1997; 71: 4782-4790.
17. Chillon M, Bosch A, Zabner J, et al. Group D adenoviruses infect primary central nervous system cells more efficiently than those from group C. J Virol 1999; 73: 2537-2540.
18. Shayakhmetov DM, Papayannopoulou T, Stamatoyannopoulos G, Lieber A. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector. J Virol 2000; 74: 2567-2583.
19. Mizuguchi H, Hayakawa T. Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes. Gene 2002; 289: 69-77.
20. Hidaka C, Milano E, Leopold P, et al. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts. J Clin Invest 1999; 103: 579-587.
21. Staba MJ, Wickham TJ, Kovesdi I, Hallahan DE. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models. Cancer Gene Ther 2000; 7: 13-19.
22. Hay CM, De Leon H, Jafari JD, et al. Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob. J Vasc Res 2001; 38: 315-323.
23. Gonzalez R, Vereecque R, Wickham TJ, et al. Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein. Gene Ther 1999; 6: 314-320.
24. Gonzalez R, Vereecque R, Wickham TJ, et al. Transduction of bone marrow cells by the AdZ.F(pK7) modified adenovirus demonstrates preferential gene transfer in myeloma cells. Hum Gene Ther 1999; 10: 2709-2717.
25. Asaoka K, Tada M, Sawamura Y, Ikeda J, Abe H. Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the coxsackievirus and adenovirus receptor. J Neurosurg 2000; 92: 1002-1008.
26. Mizuguchi H, Koizumi N, Hosono T, et al. CAR- or αv integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice. Gene Ther 2002; 9: 769-776.
27. Mizuguchi H, Kay MA. Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum Gene Ther 1998; 9: 2577-2583.
28. Mizuguchi H, Kay MA. A simple method for constructing E1 and E1/E4 deleted recombinant adenovirus vector. Hum Gene Ther 1999; 10: 2013-2017.
29. Koivunen E, Wang B, Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology 1995; 13: 265-270.
30. Pasqualini R, Koivunen E, Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997; 15: 542-546.
31. Maizel JVJ, White DO, Scharff MD. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 1968; 36: 115-125.
32. Kanegae Y, Makimura M, Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 1994; 47: 157-166.
33. Ito M, Kodama M, Masuko M, et al. Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circ Res 2000; 86: 275-280.
34. Mizuguchi H, Hatakawa T. Enhanced anti-tumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase. Cancer Gene Ther 2002; 9: 236-242.
35. Thomas CE, Edwards P, Wickham TJ, Castro MG, Lowenstein PR. Adenovirus binding to the coxsackievirus and adenovirus receptor or integrins is not required to elicit brain inflammation but is necessary to transduce specific neural cell types. J Virol 2002; 76: 3452-3460.
36. Wu H, Seki T, Dmitriev I, et al. Hum Gene Ther 2002; 13: 1647-1653.